找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Endoscopy in Early Gastrointestinal Cancers, Volume 2; Treatment Philip W. Y. Chiu,Yasushi Sano,Rajvinder Singh Book 2021 Springer Nature S

[復(fù)制鏈接]
樓主: 鳴叫大步走
41#
發(fā)表于 2025-3-28 18:17:03 | 只看該作者
42#
發(fā)表于 2025-3-28 18:54:35 | 只看該作者
43#
發(fā)表于 2025-3-28 23:01:10 | 只看該作者
44#
發(fā)表于 2025-3-29 05:43:50 | 只看該作者
45#
發(fā)表于 2025-3-29 08:21:10 | 只看該作者
Individualism-Collectivism and Saving Face, of ≥1000?μm or lesions with lymphovascular involvement, poorly differentiated/signet-ring cell/mucinous carcinoma, or budding grades 2 and 3 (high-risk submucosally invasive cancer); and surgical colorectomy with lymph node dissection is indicated. Endoscopists should know how to appropriately manage these lesions since ER is not always perfect.
46#
發(fā)表于 2025-3-29 14:18:42 | 只看該作者
Toxic chemicals and hazardous wastes2?mg/dL or the requirement for blood transfusion [2]. However, these definitions have not been established on the basis of solid evidence. The presence of marked bloody stool after treatment or the requirement for a certain measure for hemostasis after treatment is often defined as delayed bleeding.
47#
發(fā)表于 2025-3-29 18:02:20 | 只看該作者
48#
發(fā)表于 2025-3-29 21:11:17 | 只看該作者
Management of Non-curative Resection and Local Recurrence After Endoscopic Resection: Non-curative onfined to the superficial part of the esophageal wall. Endoscopic submucosal dissection (ESD), rather than endoscopic mucosal resection (EMR), is the preferred approach owing to the superior performance to tackle potential submucosal fibrosis in these conditions.
49#
發(fā)表于 2025-3-30 02:19:07 | 只看該作者
Management of Non-curative Resection and Local Recurrence after Endoscopic Resection: Non-curative patients, additional surgery should be considered carefully based not only on the tumor-related factors, but also on the patient factors, such as age, comorbidities, PS, dementia, and Patient’s and family’s opinions on life and death.
50#
發(fā)表于 2025-3-30 05:11:35 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-6 09:08
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
孟津县| 山西省| 营山县| 沙湾县| 临海市| 昌邑市| 杂多县| 鄂伦春自治旗| 上杭县| 马公市| 杭州市| 景谷| 甘泉县| 康乐县| 象州县| 河东区| 宜春市| 昌平区| 德令哈市| 牙克石市| 明星| 齐河县| 嘉鱼县| 紫金县| 霍山县| 平度市| 延川县| 镇平县| 六盘水市| 左云县| 叙永县| 云阳县| 福贡县| 萍乡市| 灌南县| 安平县| 榕江县| 贵定县| 乐亭县| 新安县| 黄冈市|